Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systo (Q84622095)
Jump to navigation
Jump to search
scientific article published on 01 October 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systo |
scientific article published on 01 October 2009 |
Statements
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial (English)
William T Abraham
Claude Daubert
Michael R Gold
Grahame Goode
Tamás Szili-Török
REVERSE Study Group